Pharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2025 ,inter alia, to consider and approve the Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pharmaids Pharmaceuticals has informed BSE that its Board of Directors will meet on Friday, 23rd May 2025 to consider and approve the Audited Financial Results (both Standalone and Consolidated) for the quarter and financial year ended March 31, 2025. The company has also clarified that the trading window for dealing in its securities will remain closed for Designated Persons and their immediate relatives until 48 hours after the results are declared to the stock exchange. The intimation was filed by Company Secretary Prasanna Subramanya Bhat on 20th May 2025 under SEBI LODR Regulation 29.
This is a routine regulatory intimation with no new financial data. Investors should watch for the actual audited results on or after 23rd May 2025 for any meaningful insight into the company's full-year performance. The closed trading window is standard practice to prevent insider trading ahead of results.